GATOR1 complex controls cisplatin sensitivity
Zhenrui Pan, Hanxiao Zhang, Xia Xiao, Catherine Brenner, Svetlana Dokudovskaya · 2025
Read GATOR1 complex controls cisplatin sensitivity by Zhenrui Pan, Hanxiao Zhang, Xia Xiao, Catherine Brenner, Svetlana Dokudovskaya (2025) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-12824275.txt.
Description
Cisplatin is a frontline chemotherapy drug, but tumors often learn to resist it. Zhenrui Pan and four co-authors study the GATOR1 complex, a three-protein brake on cell growth signaling, long tied to nutrient sensing. They compare normal airway cells with the complex deleted against lung cancer lines that acquired resistance.
Deleting any GATOR1 member made cells resistant, while restoring it made them sensitive again. Resistant cells pumped the drug out faster, let less in, and so suffered fewer DNA hits, even as their damage response ran hotter. A growth-signaling blocker restored sensitivity alongside the complex. Gene scans of the deleted cells revealed new signatures of the resistance program. The authors argue this second job of GATOR1 should shape anti-resistance strategies. The study appears in 2025.
Catalog record
| CREATOR | Zhenrui Pan, Hanxiao Zhang, Xia Xiao, Catherine Brenner, Svetlana Dokudovskaya |
|---|---|
| YEAR | 2025 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 75 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |